Citation Impact
Citing Papers
Prognostic Utility of Anti-EBV Antibody Testing for Defining NPC Risk among Individuals from High-Risk NPC Families
2011
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Features, Evaluation and Treatment Coronavirus (COVID-19)
2020 Standout
Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up
2011
SARS and MERS: recent insights into emerging coronaviruses
2016 Standout
Purification, crystallization and preliminary crystallographic studies of the complex of interferon-λ1 with its receptor
2009
Detection of Stage I nasopharyngeal carcinoma by serologic screening and clinical examination
2011
Type I interferons in infectious disease
2015 Standout
Hyperimmune IV Immunoglobulin Treatment
2013
Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1
2010
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
2018 Standout
Coronavirus envelope protein: current knowledge
2019 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
The cytokine storm of severe influenza and development of immunomodulatory therapy
2015 Standout
Single Nucleotide Polymorphisms within Interferon Signaling Pathway Genes Are Associated with Colorectal Cancer Susceptibility and Survival
2014
Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity
2007
Nasopharyngeal carcinoma
2015 Standout
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
Interspecies transmission and emergence of novel viruses: lessons from bats and birds
2013
The spike protein of SARS-CoV — a target for vaccine and therapeutic development
2009
AAV Vectors Vaccines Against Infectious Diseases
2014
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective
2020 Standout
Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology
2010
Structural basis of receptor recognition by SARS-CoV-2
2020 StandoutNature
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients
2011
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections
2014 StandoutNobel
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
2020 Standout
Peptido-organic Diels–Alder reactions on hydrophilic resin: scope for combinatorial chemistry
2001 StandoutNobel
Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
2014
Peptidmimetica für Rezeptorliganden – Entdeckung, Entwicklung und medizinische Perspektiven
1993
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
A Field Guide to Foldamers
2001 Standout
N-Terminal Peptide Aldehydes as Electrophiles in Combinatorial Solid Phase Synthesis of Novel Peptide Isosteres
2000 StandoutNobel
Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma
2004
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
1993
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Type I IFNs Downregulate Myeloid Cell IFN-γ Receptor by Inducing Recruitment of an Early Growth Response 3/NGFI-A Binding Protein 1 Complex That Silences ifngr1 Transcription
2013
Synthesis of Aldehyde Building Blocks Protected as Acid Labile N-Boc N,O-Acetals: Toward Combinatorial Solid Phase Synthesis of Novel Peptide Isosteres
2000 StandoutNobel
Works of Fai Ng being referenced
Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines
2006
Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection
2006
Identification of the Aspartimide Structure in a Previously-Reported Peptide
1990
EBV specific antibody‐based and DNA‐based assays in serologic diagnosis of nasopharyngeal carcinoma
2003
A regulatory polymorphism in interferon-γ receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection
2009
Wild Type and Mutant 2009 Pandemic Influenza A (H1N1) Viruses Cause More Severe Disease and Higher Mortality in Pregnant BALB/c Mice
2010